A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Subjects

NCT00540501 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Contract agreement not reached

Conditions

Healthy Subjects

Interventions

DRUG: Oseltamivir and Intravenous Zanamivir

Sponsor

GlaxoSmithKline